Delivery Order SPE2DB20D1051-SPE2DB24FD7NX

Award Date 4/1/24
Potential Completion Date 4/2/24
Potential Value $1.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $10,587.49 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Contrave ER 8-90 mg tablets to support military treatment programs and facilities. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Contrave ER 8-90 mg tablets in quantities of 120 tablets. The contract has a potential value of $6,095.95 and a completion date of February 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a potential value of $9,813.88 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is a for-profit organization and the prime contractor on this award. The contract is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,351.80 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. This $6,046.50 firm fixed price contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. The company also holds an indefinite delivery contract (IDC) with DLA, valued...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,250.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 120 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $10,867.51 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. This delivery order, which does not have a set-aside designation, is for the supply of 4563993439 - CONTRAVE ER 8-90 MG TABLET 120S. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Contrave ER 8-90 mg tablets. The contract has a ceiling value of $18,065.42 and a period of performance through April 12, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 with a performance period through December 31, 2025, which serves as...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $13,675.32 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The delivery order is for CONTRAVE ER 8-90 MG TABLET 120S and has a completion date of March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which is not designated as a set-aside...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of CONTRAVE ER 8-90 MG TABLET 120S. The $4,555.98 contract has a completion date of February 6, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this award, which is issued under an indefinite delivery contract (IDC) with a potential...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB24FD7NX
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Contrave ER 8-90 mg tablets. The contract, valued at $1,814.81, has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and this award is associated with a $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 7/1/24, 9:07 AM